Fatma Gul, MD
Physical Medicine & Rehabilitation · Dallas, TXNPI 1346233517
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (33.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AbbVie at 57.1% of the total. Reporting peaked in 2019 at $16,671 and has fallen 99.5% since, to $87 in 2025. Among physical medicine & rehabilitation clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $186.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Medtronic$3K
- Saol Therapeutics Inc.$2K
- Ipsen Pharma SAS$1K
- Neurocrine Biosciences, Inc.$1K
- Merz Pharmaceuticals, LLC$555
- plus $976 from 5 others
Across 853 payments — averaging $648.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Pharma SAS$261K
- Merz Pharmaceuticals, LLC$163K
- MDD US Operations, LLC$65K
- AbbVie$55K
- Merz North America, Inc.$8K
- Neurocrine Biosciences, Inc.$3K
What the payments were for
- Consulting fees$6,23030%
- Speaking & faculty fees$6,97534%
- Travel & lodging$2,24111%
- Food & beverage$4,71423%
- Education$850%
- Gifts$3152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $11,743 |
| Medtronic(2 entities) | 30 | $2,647 |
| Saol Therapeutics Inc. | 11 | $2,312 |
| Ipsen Pharma SAS | 5 | $1,175 |
| Neurocrine Biosciences, Inc. | 10 | $1,152 |
| Merz Pharmaceuticals, LLC | 10 | $555 |
| Ipsen Biopharmaceuticals, Inc | 9 | $487 |
| Merz North America, Inc. | 2 | $297 |
| Pacira Pharmaceuticals Incorporated | 2 | $160 |
| Tersera Therapeutics LLC | 1 | $16 |
| MDD US Operations, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$11,018
- LIORESAL$2,098
- SYNCHROMED$1,759
- DYSPORT$1,330
- SYNCHROMEDII$252
- XEOMIN$173
How this compares
$20,560 in reported general payments places this provider in the 95th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 11 | $8,548 |
| Pregabalin | 32 | $6,483 |
| Baclofen | 97 | $3,449 |
| Glycopyrrolate | 15 | $1,701 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $1,493 |
| Fentanyl | 11 | $1,223 |
| Gabapentin | 22 | $1,083 |
| Dantrolene Sodium | 24 | $1,015 |
| Morphine Sulfate | 12 | $467 |
| Oxycodone Hcl | 19 | $419 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $389 |
| Tizanidine Hcl | 26 | $291 |
| Hydromorphone Hcl | 11 | $156 |
| Diazepam | 23 | $113 |
| Trazodone Hcl | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Dallas
- Gireesh ShardaDallas$172K
- Priya ChittaDallas$15K
- Nikesh PatelDallas$14K
- Surendra BarshikarDallas$11K
- Rinoo ShahDallas$7K
- Gerard FranciscoHouston$364K
- Jose UrquidezAustin$332K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Chad McNeilTyler$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.